Scenario 1: Private Insurance with Manufacturer Program Profile: 45-year-old with employer-provided insurance (Sun Life), BMI 35, type 2 diabetes Coverage: Insurance approves after prior authorization, covers 70% after $500 deductible Calculation: Annual retail cost: $21,000 Deductible: $500 Insurance pays 70% of remaining $20,500 = $14,350 Patient owes: $6,650 Manufacturer program saves: $2,800 Final patient cost: $3,850 annually ($320/month) Verdict: Most affordable scenario
Since weight loss is one of the beneficial effects of the Semaglutide injection, health care providers have started to prescribe it for the treatment of obesity even to patients who don't have type 2 diabetes
Cost: 73% of all discontinuations happen here
Based on its mechanism of action, this multi-receptor approach is hypothesised to reduce appetite, support glucose regulation, and increase energy expenditure though these effects remain under investigation and have not yet been confirmed through completed Phase 3 trials
The tolerability was honestly what sold me
